CLINICAL TRIAL NETWORK NAMED IN TOP HALF OF INC MAGAZINE 500 I 5000 LIST

HOUSTON – Clinical Trial Network (CTN) made its debut appearance on the Inc. Magazine: 2012 Inc. 500I5000 List at 2,147. The clinical research company, located in Southwest Houston, made the list based on its overall growth throughout the last three years.

The 2012 Inc. 500I5000 List is the most comprehensive portrait of America’s fastest-growing private companies. It is ranked according to percentage revenue growth from 2008 to 2011 and in order to qualify, companies are required to have minimum revenue of $100,000 in 2008 and $2 million for 2011.

“We are very honored to be part of such a prestigious list,” Dr. Nawab Baloch, owner and Site Director of CTN said.  “This award demonstrates what clear vision, determination, and ambition can accomplish.”

CTN continues to grow with its recent building acquisition at 7080 Southwest Freeway and will transform the space into a state-of-the-art, Multi-Specialty Clinical Research (MSCR) facility.

The renovated 20,000 sq. ft. building is set to open in January 2013 and will allow CTN to provide quality medical attention and opportunities to participate in clinical trials to the surrounding underserved community.

Additionally, the building will include an in-house family practice clinic, an on-site pharmacy, and eventually dental care, eye care and urgent care capabilities. Free monthly education seminars regarding topics such as health and wellness, nutrition, and diabetes-related topics, such as potential complications caused by diabetes, to all patients.

“We are confident this expansion will thrust CTN into the top Inc. 500 List next year,” Dr. Nawab Baloch said. “And we are even more excited at all the jobs it will create for the Houston area.”

About Clinical Trial Network (CTN)

Founded in 2004, Clinical Trial Network is a privately owned, state-of-the-art, Multi-Specialty Clinical Research (MSCR) facility, located in Houston, Texas. CTN owns and operates industry-leading clinical research sites that specialize in a full range of indications. Currently, CTN specializes and conducts research of multiple therapeutic indications such as Diabetes, Cholesterol, Hypertension, Pain, and Constipation to name a few. Capabilities continue to grow and CTN is able to conduct research in all four phases (Phase I, II, III, IV) of clinical research trials, while consistently delivering speed and quality to all pharmaceutical and bio-technology clients as well as all leading Contract Research Organizations (CROs). Past and current CTN clients include Johnson & Johnson, ABBOTT, Pfizer, GSK, Sucampo, Nova Nordisk, Novartis, and AstraZeneca among others.

CTN named among the 2012 ICIC ICIC Inner City 100 Award Recognizing 100 Fastest-Growing Urban Business in America among Goldman Sachs “Companies to Watch” Award; and in 2011, received the Star Award for Economic Development from the Houston West Chamber of Commerce.

For more information, please contact 713-484-6947 or Andrea Sedeno at asedeno@ctntexas.com